7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference 2023 is Back!
The 7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference will be held on March 9-10, 2023 in London, UK. The conference combines 3 themes: genomics, next generation proteomics, and precision medicine and various presentations and discussions. Q & A sessions and exhibitions are planned.
The conference will cover the following topics:
- Challenges and future directions in Immuno Oncology research
- New developments of ADCs, bispecific antibodies, cell therapy and immune checkpoint inhibitors
- Various combination strategies, preclinical and translational developments in immuno-oncology, updates in cell and viral therapies, vaccine development, and personalized immunotherapy
It brings together more than 20 scientific speakers around the world from pharmaceutical, biopharmaceutical and biotechnology companies.
This is a great opportunity to share and discuss with us! Please register here.
Presentation during the event by:
Sebastien Tabruyn, PhD Chief Scientific Officer
Sebastien Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). After 20 years of experience as a Project Leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia), and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 to develop the first IO humanized mouse models. Sebastien Tabruyn has published more than 30 peer-reviewed publications mostly focused on oncology, inflammation, immunity, and angiogenesis.
Attending for TransCure bioServices:
Touyana Semenova PhD, Business Development
Touyana Semenova holds a PhD in Virology, Microbiology, Immunology from the Université Grenoble Alpes, France. She worked as a Clinical Research Coordinator at the Grenoble University Hospital for the ANRS and GEMHEP, then as a researcher at the University of Florida in the United States in the field of Infectious Diseases & Immunology. She joined TransCure bioServices as a Project Leader in 2020, and now works with us as a Business Developer.